Big pharma thinks twice about jacking up drug pricesMichael Pearson, chief executive of
Valeant, has completed several “buy and raise” deals in recent years. In February, Valeant bought the rights to two life-saving heart drugs and
raised the prices overnight, one by 525 per cent and the other 212 per cent.
https://www.ft.com/intl/cms/s/0/1ed232c0-6d2c-11e5-8171-ba1968cf791a.html#axzz3ntkEIAXl
--------------------
Which kind of heartless racket is that? Preying on the lives of sick people, this is truly sickening. Not to mention the tax avoiding structures they use. This company is a disgrace on so many levels.
Nawar